Author:
Shaikh Aadil Ashraf Ahmed,Boniface Mary Ann,Husain Syed Ammar,Naeem Nida,Husain Syed Arshad
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Tuberculosis. (2023). Accessed. August 2024: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.
2. Dupilumab for treating severe asthma with type 2 inflammation. (2021). Accessed. August 2024: https://www.nice.org.uk/guidance/ta751/chapter/1-Recommendations.
3. Dupilumab efficacy and safety in patients with moderate to severe asthma: a systematic review and meta-analysis;Zaazouee MS;Front Pharmacol,2022
4. A novel combined use of Dupilumab for treatment of aggressive refractory pemphigus vulgaris complicated with pulmonary tuberculosis: a case report and the RNA-seq analysis;Chen S;Front Immunol,2022
5. Safety of biologics for psoriatic patients with latent tuberculosis;Yuan L;Clin Cosmet Investig Dermatol,2023